# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-047102
Filing Date
2024-11-12
Accepted
2024-11-12 16:02:33
Documents
65
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | sgmo-20240930.htm iXBRL | 10-Q | 1185815
2 | EX-10.1 | sgmo-20240930xex101.htm | EX-10.1 | 608753
3 | EX-10.2 | thirdamendmenttoleaseagr.htm | EX-10.2 | 6798
4 | EX-31.1 | sgmo-20240930xex311.htm | EX-31.1 | 10023
5 | EX-31.2 | sgmo-20240930xex312.htm | EX-31.2 | 10138
6 | EX-32.1 | sgmo-20240930xex321.htm | EX-32.1 | 7142
12 | GRAPHIC | thirdamendmenttoleaseagr001.jpg | GRAPHIC | 239297
13 | GRAPHIC | thirdamendmenttoleaseagr002.jpg | GRAPHIC | 160693
14 | GRAPHIC | thirdamendmenttoleaseagr003.jpg | GRAPHIC | 61638
| Complete submission text file | 0001628280-24-047102.txt |  | 7445582

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | sgmo-20240930.xsd | EX-101.SCH | 41724
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | sgmo-20240930_cal.xml | EX-101.CAL | 62345
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | sgmo-20240930_def.xml | EX-101.DEF | 208536
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | sgmo-20240930_lab.xml | EX-101.LAB | 464976
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | sgmo-20240930_pre.xml | EX-101.PRE | 341214
68 | EXTRACTED XBRL INSTANCE DOCUMENT | sgmo-20240930_htm.xml | XML | 870999

Mailing Address 501 CANAL BLVD. RICHMOND CA 94084
Business Address 501 CANAL BLVD. RICHMOND CA 94084 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 241447827
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)